Coronavirus

Latest News

 Evaluating the Efficacy of Paxlovid in High-Risk Patients with Pre-Existing Immunity
Evaluating the Efficacy of Paxlovid in High-Risk Patients with Pre-Existing Immunity

October 22nd 2024

John McLaughlin, PhD, examines high-risk individuals with prior SARS-CoV-2 immunity and presents that Paxlovid reduces the risk of hospitalization, death, and severe symptoms, highlighting its ongoing value for high-risk patients in a post-peak pandemic landscape.

Original COVID-19 Strain Greatly Increased Risk for Heart Attack, Stroke, Death
Original COVID-19 Strain Greatly Increased Risk for Heart Attack, Stroke, Death

October 11th 2024

The Underuse of COVID-19 Antiviral Treatments in Older Adults
The Underuse of COVID-19 Antiviral Treatments in Older Adults

October 11th 2024

FDA Grants Authorization for First OTC Influenza and COVID-19 Test Outside Emergency Use
FDA Grants Authorization for First OTC Influenza and COVID-19 Test Outside Emergency Use

October 7th 2024

Phase 2/3 Trial of New Omicron-Targeted Vaccine Shows Efficacy in Adolescents
Phase 2/3 Trial of New Omicron-Targeted Vaccine Shows Efficacy in Adolescents

September 30th 2024

© 2024 MJH Life Sciences

All rights reserved.